Bayer sues Novartis unit over generic YAZ
Bayer filed suit against Sandoz, Novartis' generic-drug unit, to block the company from launching its version of YAZ, a blockbuster birth-control pill, in the U.S. Bayer also sued Sandoz and other generic-drug makers seeking approval to market copies of a related treatment, Yasmin, after losing a patent dispute with Barr Pharmaceuticals.
Bloomberg | 08/04
This story published in FMI Pharmacy dailyLead on 08/05/2008
Get stories like these delivered daily for FREE:
|
FMI Pharmacy dailyLead
Designed specifically for pharmacy professionals, FMI Pharmacy dailyLead is a FREE, daily e-mail newsletter. It provides the latest news in the pharmacy arena. Learn more |
|